Search Results
Found 1 results
510(k) Data Aggregation
(112 days)
Next Science Wound Gel (Rx)
Next Science Wound Gel (Rx) is indicated for the management of wounds such as Stage I-IV pressure ulcers, partial and full thickness wounds, diabetic foot and leg ulcers, post-surgical wounds, first and second degree burns, grafted and donor sites.
Next Science Wound Gel is a hydrogel that helps to maintain a moist wound environment that is conducive to healing. The antimicrobial agent, benzalkonium chloride, inhibits the growth of microorganisms in the hydrogel. The Wound Gel is applied directly to the wound and then covered with an appropriate dressing. The use of the hydrogel on a wound creates a moist environment that is conducive to healing by either absorbing wound exudate or donating moisture. The Wound Gel will be supplied in both 1 ounce and 4-ounce low-density polyethylene tubes with a screw-top opening. Lot number and expiration dating will be embossed on the printed tube.
The provided text describes a 510(k) premarket notification for a medical device called "Next Science Wound Gel (Rx)". This document focuses on demonstrating substantial equivalence to predicate devices rather than proving the device meets specific acceptance criteria through a clinical study with an AI component.
Therefore, many of the requested details, such as:
- A table of acceptance criteria and reported device performance (in the context of AI)
- Sample sizes for test sets (for AI)
- Number of experts and their qualifications (for AI ground truth)
- Adjudication method (for AI ground truth)
- MRMC comparative effectiveness study results (AI assistance)
- Standalone performance (AI algorithm only)
- Type of ground truth used (for AI)
- Sample size for training set (for AI)
- How ground truth for training set was established (for AI)
are not applicable or available in this document. The document concerns a physical medical device (wound gel) and its biological and functional performance, not an AI/software device.
However, I can extract the information relevant to the device's performance testing and the grounds for its substantial equivalence.
Here's what can be extracted:
1. Acceptance Criteria and Reported Device Performance (as related to the physical device properties):
The document doesn't present a table of quantitative acceptance criteria for biological or clinical performance in the typical sense of an AI/diagnostic study, but rather demonstrates compliance with safety and effectiveness standards through various tests and comparison to predicates.
Acceptance Criteria Category | Reported Device Performance / Support |
---|---|
Biocompatibility | Compliant with the requirements of ISO 10993. These studies demonstrated that Next Science™ Wound Gel is safe for the indicated use. |
Functional Performance | The gel's ability to aid in the management of wounds has been demonstrated by a full thickness wound study. (No specific quantitative performance metrics from this study are provided in the summary, just that it was conducted and demonstrated ability). The product description states it "helps to maintain a moist wound environment that is conducive to healing." |
Preservative Efficacy / Microbial Inhibition | Demonstrated through **USP Antimicrobial Effectiveness Testing and ** to demonstrate that the Wound Gel will not introduce bacteria to the application site. The antimicrobial agent, benzalkonium chloride, "inhibits the growth of microorganisms in the hydrogel." (No specific microbial inhibition rates or spectrum are provided in this summary, other than the general statement and the tests confirming efficacy). For comparison, the predicate Anasept Antimicrobial Skin and Wound Gel is stated to inhibit specific bacteria (Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, Serratia marcescens, Acinetobacter baumannii, MRSA, VRE) and fungi (Candida albicans and Aspergillus niger). While not directly an acceptance criterion for the Next Science gel, it provides context for the expected performance in this category. |
Shelf-life | Testing was conducted to support substantial equivalence. (No specific duration or stability metrics are provided). |
Substantial Equivalence | The device has the same indications for use as the predicate device (Anasept Antimicrobial Skin and Wound Gel) and the same technological characteristics as another predicate device (Next Science Wound Gel (OTC)). Performance testing demonstrates it is at least as safe and effective as the predicate devices. |
2. Sample Sample(s) Used for the Test Set and Data Provenance:
- Test Set (for the gel's performance): The document mentions a "full thickness wound study" and "biocompatibility studies" and "USP Antimicrobial Effectiveness Testing and ".
- Sample Size: Not specified for any of these studies.
- Data Provenance: Not specified (e.g., country of origin). The studies appear to be laboratory or preclinical studies demonstrating functional and safety aspects of the gel, not clinical trials with human patient data. These would be considered prospective data generation for the purpose of demonstrating device characteristics.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications:
- Not applicable: This document describes a physical medical device (wound gel) and its chemical/biological properties and performance studies (biocompatibility, antimicrobial effectiveness, wound healing observation), not an AI/software device requiring expert human readers to establish ground truth for image interpretation or similar.
4. Adjudication Method for the Test Set:
- Not applicable: As above, this is not an AI/diagnostic study scenario where human adjudication of interpretations is required.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done:
- No: This is not relevant to the presented device approval (wound gel). There is no AI component mentioned in this document.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was Done:
- No: This is not relevant to the presented device approval (wound gel). There is no AI component mentioned in this document.
7. The Type of Ground Truth Used:
- For the physical properties and performance of the gel:
- Biocompatibility: Likely based on established ISO 10993 standards and assays, with "ground truth" being the measured biological reaction (e.g., cytotoxicity, irritation) against control limits.
- Functional Performance (Wound Study): Likely observational data on wound healing, potentially compared to controls or predicate devices.
- Preservative Efficacy: Based on quantitative microbial reduction/inhibition as defined by USP standards.
8. The Sample Size for the Training Set:
- Not applicable: This is a physical medical device, not an AI/machine learning model that requires a training set.
9. How the Ground Truth for the Training Set was Established:
- Not applicable: This is a physical medical device, not an AI/machine learning model that requires a training set.
Ask a specific question about this device
Page 1 of 1